DELOGU, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 4.059
NA - Nord America 1.987
SA - Sud America 1.189
EU - Europa 580
AF - Africa 292
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.113
Nazione #
US - Stati Uniti d'America 1.866
SG - Singapore 1.473
VN - Vietnam 918
BR - Brasile 867
CN - Cina 558
HK - Hong Kong 502
BD - Bangladesh 255
ZA - Sudafrica 220
IT - Italia 199
FR - Francia 188
AR - Argentina 128
EC - Ecuador 70
IN - India 67
MX - Messico 66
ID - Indonesia 50
CO - Colombia 40
DE - Germania 34
IQ - Iraq 34
CA - Canada 26
PY - Paraguay 25
RU - Federazione Russa 25
PH - Filippine 23
VE - Venezuela 23
GB - Regno Unito 22
TR - Turchia 22
MA - Marocco 17
PK - Pakistan 17
SA - Arabia Saudita 17
ES - Italia 14
TH - Thailandia 14
UA - Ucraina 14
UZ - Uzbekistan 14
CL - Cile 12
JP - Giappone 12
MY - Malesia 12
NL - Olanda 12
EG - Egitto 10
KE - Kenya 10
PE - Perù 10
PL - Polonia 10
DZ - Algeria 8
KZ - Kazakistan 8
SE - Svezia 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
ET - Etiopia 7
IE - Irlanda 6
JM - Giamaica 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
AL - Albania 5
BH - Bahrain 5
CH - Svizzera 5
KR - Corea 5
AO - Angola 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
IR - Iran 4
JO - Giordania 4
MD - Moldavia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
CR - Costa Rica 3
FI - Finlandia 3
QA - Qatar 3
RS - Serbia 3
BE - Belgio 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
SN - Senegal 2
SR - Suriname 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
GP - Guadalupe 1
KH - Cambogia 1
KW - Kuwait 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
Totale 8.106
Città #
Dallas 536
San Jose 504
Hong Kong 485
Singapore 434
Ho Chi Minh City 332
Hanoi 199
Johannesburg 198
Lauterbourg 176
Ashburn 124
Beijing 122
Boardman 97
São Paulo 76
Los Angeles 74
Buffalo 61
New York 48
Da Nang 43
Mexico City 35
Haiphong 31
Columbus 28
Milan 26
Guayaquil 24
Quito 24
Rio de Janeiro 24
Rome 24
Hefei 23
Munich 20
Brasília 19
Belo Horizonte 18
Biên Hòa 18
Hải Dương 18
Baghdad 16
Porto Alegre 16
Shanghai 16
Thái Nguyên 14
Can Tho 13
Curitiba 13
Fortaleza 13
Parma 13
Salvador 13
Tashkent 12
Thái Bình 12
Bắc Ninh 11
Naples 11
Council Bluffs 10
Dhaka 10
Guangzhou 10
Joinville 10
Tianjin 10
Atlanta 9
Casablanca 9
Hyderabad 9
Nairobi 9
Ninh Bình 9
Santa Clara 9
Warsaw 9
Bangkok 8
Bogotá 8
Charlotte 8
Chennai 8
Jakarta 8
Jeddah 8
London 8
Orem 8
Quảng Ngãi 8
Toronto 8
Zhengzhou 8
Asunción 7
Cuenca 7
Córdoba 7
Frankfurt am Main 7
Guarulhos 7
Ha Long 7
Monte Grande 7
Montevideo 7
Phoenix 7
Santo André 7
Addis Ababa 6
Bauru 6
Brooklyn 6
Buenos Aires 6
Cape Town 6
Changsha 6
Ciudad del Este 6
Dublin 6
Hortolândia 6
La Plata 6
Montreal 6
Nuremberg 6
Phủ Lý 6
Seattle 6
Stockholm 6
São Bernardo do Campo 6
Uberaba 6
Uberlândia 6
Boston 5
Campinas 5
Canoas 5
Caracas 5
Diadema 5
Istanbul 5
Totale 4.423
Nome #
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 204
Comparative genomic analysis of bacteriocin genes in Lactobacillus crispatus strains 127
ADHESIVENESS OF BACILLUS-SUBTILIS STRAINS TO EPITHELIAL-CELLS CULTURED IN-VITRO 111
Current Evidence on the Relation Between Microbiota and Oral Cancer—The Role of Fusobacterium nucleatum—A Narrative Review 100
The Potential Role of the Microbiome in the Pathogenesis of Nasal Tumors: A Comprehensive Review 98
The activity of cell-free supernatant of Lactobacillus crispatus M247: a promising treatment against vaginal infections 95
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 93
Short-term gut microbiota’s shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 80
Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations 78
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 76
Carbon nanomaterials: a new way against tuberculosis 73
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases 67
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection 66
A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles 66
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 65
Molecular typing of Mycobacterium tuberculosis strains: A fundamental tool for tuberculosis control and elimination 63
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 62
Alternative therapies against Mycobacterium abscessus infections 62
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung 62
Secrets and lies of host-microbial interactions: MHC restriction and trans-regulation of T cell trafficking conceal the role of microbial agents on the edge between health and multifactorial/complex diseases 61
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 61
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 61
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis Infection in Children 60
The PPE domain of PPE17 is responsible for its surface localization and can be used to express heterologous proteins on the mycobacterial surface. 60
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 59
Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease. 59
Lifestyles and ageing: targeting key mechanisms to shift the balance from unhealthy to healthy ageing 57
Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy 57
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 56
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 56
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 55
Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature 55
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease 55
C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay 54
The spectrum of tuberculosis infection: new perspectives in the era of biologics 53
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis 52
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 52
HINTT working group within the GABRIEL network. (2020) Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study 51
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 51
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 50
Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis 50
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 48
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 48
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 48
Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children 47
Bacillus cereus keratitis associated with contact lens wear 47
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 47
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 47
Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli 46
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 46
M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2. 45
The biology of mycobacterium tuberculosis infection 45
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 45
Tuberculosis patients are characterized by a low-IFN-gamma/high-TNF-alpha response to methylated HBHA produced in M. smegmatis 45
PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo 44
Mycobacterium tuberculosis virulence: insights and impact on vaccine development 44
Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis 44
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 44
Prospective Evaluation of Epidemiological, Clinical, and Microbiological Features of Pandemic Influenza A (H1N1) Virus Infection in Italy 44
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 44
Development of antitubercular compunds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies 44
A Twenty-year Retrospective Study of Pediatric Tuberculosis in Two Tertiary Hospitals in Rome 43
Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia 43
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 43
In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion 43
Specific T Cells Restore the Autophagic Flux Inhibited by Mycobacterium tuberculosis in Human Primary Macrophages 42
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 42
Children and COVID-19: Microbiological and immunological insights 42
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy 42
Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector 42
Understanding cutaneous tuberculosis: two clinical cases 42
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences 41
DNA Vaccination against Tuberculosis: Expression of an Ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity 41
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host-pathogen interaction 41
Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011 41
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 41
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 40
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 40
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 40
First description of agonist and antagonist IP-10 in urine of patients with active TB 40
Isolation and identification of Mycobacterium neoaurum from a patient with urinary infection 40
Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome 39
Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment 39
Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice 39
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. On Behalf Of The Gemelli-Pediatric Covid-Team 39
Monocyte‐to‐lymphocyte, neutrophil‐to‐lymphocyte and neutrophil‐to‐monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study 39
Mycobacterium smegmatis Expressing a Chimeric Protein MPT64-Proteolipid Protein (PLP) 139-151 Reorganizes the PLP-Specific T Cell Repertoire Favoring a CD8-Mediated Response and Induces a Relapsing Experimental Autoimmune Encephalomyelitis 39
PGRS domain structures: Doomed to sail the mycomembrane 39
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection 39
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 38
The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis 38
Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds 38
Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis 38
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. 38
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 38
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 38
TLR2: A CROSSROADS BETWEEN INFECTIONS AND AUTOIMMUNITY? 38
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 37
HIV-infected patients show impaired cellular immune response to influenza vaccination, compared to healthy subjects 37
Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells 37
Totale 5.341
Categoria #
all - tutte 24.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 1 0 0 0 0 1 2
2022/20234 1 0 0 0 0 0 0 0 3 0 0 0
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025822 0 1 1 0 0 1 2 1 2 1 237 576
2025/20267.451 209 965 1.398 886 777 252 693 261 920 433 386 271
2026/202729 29 0 0 0 0 0 0 0 0 0 0 0
Totale 8.314